1. Home
  2. TLSA vs MGRM Comparison

TLSA vs MGRM Comparison

Compare TLSA & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • MGRM
  • Stock Information
  • Founded
  • TLSA 2013
  • MGRM 2016
  • Country
  • TLSA United Kingdom
  • MGRM United States
  • Employees
  • TLSA N/A
  • MGRM N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • MGRM Medical/Dental Instruments
  • Sector
  • TLSA Health Care
  • MGRM Health Care
  • Exchange
  • TLSA Nasdaq
  • MGRM Nasdaq
  • Market Cap
  • TLSA 87.8M
  • MGRM 89.6M
  • IPO Year
  • TLSA 2000
  • MGRM N/A
  • Fundamental
  • Price
  • TLSA $0.79
  • MGRM $2.48
  • Analyst Decision
  • TLSA
  • MGRM Strong Buy
  • Analyst Count
  • TLSA 0
  • MGRM 1
  • Target Price
  • TLSA N/A
  • MGRM $4.00
  • AVG Volume (30 Days)
  • TLSA 1.1M
  • MGRM 34.4K
  • Earning Date
  • TLSA 02-25-2025
  • MGRM 03-14-2025
  • Dividend Yield
  • TLSA N/A
  • MGRM N/A
  • EPS Growth
  • TLSA N/A
  • MGRM N/A
  • EPS
  • TLSA N/A
  • MGRM N/A
  • Revenue
  • TLSA N/A
  • MGRM $364,999.00
  • Revenue This Year
  • TLSA N/A
  • MGRM N/A
  • Revenue Next Year
  • TLSA N/A
  • MGRM N/A
  • P/E Ratio
  • TLSA N/A
  • MGRM N/A
  • Revenue Growth
  • TLSA N/A
  • MGRM N/A
  • 52 Week Low
  • TLSA $0.41
  • MGRM $1.53
  • 52 Week High
  • TLSA $1.74
  • MGRM $4.90
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 56.56
  • MGRM 38.31
  • Support Level
  • TLSA $0.65
  • MGRM $2.66
  • Resistance Level
  • TLSA $0.70
  • MGRM $2.85
  • Average True Range (ATR)
  • TLSA 0.05
  • MGRM 0.14
  • MACD
  • TLSA 0.01
  • MGRM -0.04
  • Stochastic Oscillator
  • TLSA 100.00
  • MGRM 15.16

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About MGRM Monogram Orthopaedics Inc.

Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.

Share on Social Networks: